<DOC>
	<DOCNO>NCT00004990</DOCNO>
	<brief_summary>This study test safety effectiveness monthly dose regimen dexamethasone-a strong steroid medication-to treat patient focal segmental glomerulosclerosis ( FSGS ) . Patients disease kidney fibrosis ( scar ) proteinuria ( excessive excretion protein urine ) , half patient eventually require kidney dialysis transplant . Currently , effective treatment FSGS high-dose steroid ( prednisone ) take daily 4 6 month . However , 30 percent patient respond treatment , cause serious side effect many patient . Other drug , cyclosporin cyclophosphamide , improve proteinuria even few patient ( 10 percent ) also serious side effect . This study explore whether monthly pulse dose steroid achieve disease remission less toxicity . Adults child FSGS : 1 ) receive steroid treatment , 2 ) could tolerate daily steroid treatment , 3 ) relapse conventional steroid treatment may eligible study . Those enrolled take dexamethasone mouth 4 day every 4 week total 8 month . Patients undergo various test treatment start ( baseline ) , course treatment , follow-up visit evaluate effect treatment follow : 1. Review kidney biopsy , medical evaluation , measurement total daily urine protein excretion kidney function , psychiatric test depression mood disorder 2 . Measurements blood pressure , blood chemistry urine protein excretion - monthly treatment 3 . Questionnaire effect treatment , , mood feeling - monthly treatment 4 . Photographs face body ( underwear short tank top ) evaluate body fat distribution- baseline 8 month 5 . Eye examination cataracts glaucoma - baseline 8 month 6 . Bone density scan ( DEXA scan ) low spine hip - baseline , 4 12 month 7 . Magnetic resonance imaging ( MRI ) hips 8 . Psychological evaluation quality life evaluation - baseline , 1 , 2 8 month 9 . Blood test adrenal gland function - baseline , 4 8 month 10 . Blood urine test - 10 , 12 , 15 , 18 month Patients achieve remission ( whose urine protein level decrease normal ) complete 8 month dexamethasone take one dose stop therapy , continue follow-up . Patients achieve remission relapse may offer second course treatment .</brief_summary>
	<brief_title>Once-A-Month Steroid Treatment Patients With Focal Segmental Glomerulosclerosis</brief_title>
	<detailed_description>The objective study evaluate effectiveness toxicity alternative steroid dose regimen patient focal segmental glomerulosclerosis ( FSGS ) , use pilot study design enroll 20 patient . Although literature report variable steroid responsiveness , remission rate 30-40 percent recently report nephrotic adult patient treat daily prednisone 1 mg/kg/day least 4 month , follow taper 3-4 month . Such prolonged aggressive steroid course fraught significant morbidity , approach advocate author poor prognosis renal survival nephrotic patient FSGS achieve remission steroid treatment . We plan test eight month course high dose steroid therapy administer monthly pulse instead daily dos , comparable efficacy achieve remission , occurrence adverse steroid side effect . We plan enroll patient nephrotic syndrome due biopsy-proven FSGS , either treat , respond conventional steroid dosing regimen relapse . We plan treat monthly oral pulse dexamethasone ( 40-60 mg/d x 4 day ) , 8 month . The primary endpoint induction complete remission , define urine protein le 300 mg/d . Patients also evaluate manifestation steroid toxicity . Patients see follow interval 24 month follow study entry . If study suggest remission nephrotic syndrome attain regimen , acceptable toxicity profile , plan randomize controlled trial regimen compare daily alternate day oral steroid .</detailed_description>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Glomerulosclerosis , Focal Segmental</mesh_term>
	<mesh_term>Glomerulonephritis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>INCLUSION CRITERIA : Adults child . Biopsy proven FSGS , include idiopathic FSGS collapse FSGS , exclude HIVassociated FSGS secondary FSGS associate morbid obesity , sickle cell anemia , reflux nephropathy , chronic tubular injury , congenital renal anomaly , reduce nephron mass . Glomerular filtration rate estimate use 4 variable MDRD GFR equation , incorporate age , race , gender , serum creatinine . If disease present less equal 1 year , estimate GFR must great equal 40 ml/min . If disease present great equal 1 year , estimate GFR must great equal 60 ml/min . Nephrotic range proteinuria , define urine protein great equal 3.5 g/1.73 ( 2 ) /d . Patients receive steroid FSGS enter complete remission relapse nephrotic range proteinuria eligible . If hypertensive , adequate blood pressure control ( target BP less equal 130/80 mm Hg great 75 % measurement adult ) . Patients must take angiotensin convert enzyme inhibitor angiotensin receptor antagonist least 6 week , unless intolerant medication . Women childbearing potential must maintain effective birth control regimen ( oral contraceptive , intrauterine device , barrier plus spermicide ) . EXCLUSION CRITERIA : Inability give inform consent cooperate study . Poorly control diabetes ( define hemoglobin A1C great equal 8.5 entry screening , daily insulin requirement great equal 100 unit ) hypertension ( define systolic BP consistently great 160 and/or diastolic BP consistently great 100 three drug ) . Evidence chronic occult infection . Specifically , must evidence active hepatitis B , hepatitis C , HIV untreated mycobacterial infection . Current prior use cytotoxic agent cyclosporin FSGS . If previously treat agent nonrenal indication , therapy must conclude least 12 month prior study . Existence condition would complicate implementation interpretation study . History steroidinduced psychiatric disorder , know avascular necrosis hip symptomatic osteoporosis ( e.g. , know compression fracture ) , brittle diabetes mellitus , glaucoma . Patients psychiatric disorder evaluate case case basis . Patients treat steroids equivalent 1 mg/kg/day great equal 8 week without remission exclude .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>Nephrotic Syndrome</keyword>
	<keyword>Steroids</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Adrenal Suppression</keyword>
	<keyword>Proteinuria</keyword>
	<keyword>Focal Segmental Glomerulosclerosis</keyword>
</DOC>